HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.

Abstract
Proteinuria and hyperphosphatemia are risk factors for cardiovascular disease in patients with chronic kidney disease (CKD). Although the interaction between proteinuria and the serum phosphate level is well established, the mechanistic link between the two, particularly the extent to which this interaction is mediated by phosphate-regulating factors, remains poorly understood. In this study, we examined the association between proteinuria and the serum phosphate level, as well as potential mediators, including circulating fibroblast growth factor (FGF23)/klotho, the 24-h urinary phosphate excretion rate to glomerular filtration rate ratio (EP/GFR), and the 24-h tubular phosphate reabsorption rate to GFR ratio (TRP/GFR). The analyses were performed with data from 1793 patients in whom 24-h urine protein and phosphate, serum phosphate, FGF23, and klotho levels were measured simultaneously, obtained from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD). Multivariable linear regression and mediation analyses were performed. Total, direct, and indirect effects were also estimated. Patients with high serum phosphate levels were found to be more likely to exhibit greater proteinuria, higher FGF23 levels, and lower klotho levels. The 24-h EP/GFR increased and the 24-h TRP/GFR decreased with increasing proteinuria and CKD progression. Simple mediation analyses showed that 15.4% and 67.9% of the relationship between proteinuria and the serum phosphate level were mediated by the FGF23/klotho ratio and 24-h EP/GFR, respectively. Together, these two factors accounted for 73.1% of the relationship between serum markers. These findings suggest that proteinuria increases the 24-h EP/GFR via the FGF23/klotho axis as a compensatory mechanism for the increased phosphate burden well before the reduction in renal function is first seen.
AuthorsJi Yong Jung, Han Ro, Jae Hyun Chang, Ae Jin Kim, Hyun Hee Lee, Seung Hyeok Han, Tae-Hyun Yoo, Kyu-Beck Lee, Yeong Hoon Kim, Soo Wan Kim, Sue Kyung Park, Dong-Wan Chae, Kook-Hwan Oh, Curie Ahn, Wookyung Chung
JournalPloS one (PLoS One) Vol. 15 Issue 6 Pg. e0235077 ( 2020) ISSN: 1932-6203 [Electronic] United States
PMID32569271 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • FGF23 protein, human
  • Phosphates
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Glucuronidase
  • Klotho Proteins
Topics
  • Cohort Studies
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors (blood)
  • Glomerular Filtration Rate
  • Glucuronidase (blood)
  • Humans
  • Kidney Tubules (metabolism, pathology)
  • Klotho Proteins
  • Male
  • Middle Aged
  • Phosphates (blood)
  • Proteinuria (blood)
  • Regression Analysis
  • Renal Insufficiency, Chronic (blood, physiopathology)
  • Republic of Korea
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: